These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19187518)

  • 1. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
    Honrado ER; Fungladda W; Kamoiratanaku P; Kitayaporn D; Karbwang J; Thimasarn K; Masngammueng R
    Bull World Health Organ; 1999; 77(3):235-43. PubMed ID: 10212514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
    Rolland E; Checchi F; Pinoges L; Balkan S; Guthmann JP; Guerin PJ
    Trop Med Int Health; 2006 Apr; 11(4):398-408. PubMed ID: 16553923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.
    Lubell Y; Riewpaiboon A; Dondorp AM; von Seidlein L; Mokuolu OA; Nansumba M; Gesase S; Kent A; Mtove G; Olaosebikan R; Ngum WP; Fanello CI; Hendriksen I; Day NP; White NJ; Yeung S
    Bull World Health Organ; 2011 Jul; 89(7):504-12. PubMed ID: 21734764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis.
    Maka DE; Chiabi A; Obadeyi B; Mah E; Nguefack S; Nana P; Mbacham W; Mbonda E
    Malar J; 2016 Dec; 15(1):587. PubMed ID: 27923381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
    Newton PN; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
    Clin Infect Dis; 2003 Jul; 37(1):7-16. PubMed ID: 12830403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate for severe malaria.
    Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257
    [No Abstract]   [Full Text] [Related]  

  • 9. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
    Checkley AM; Whitty CJ
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemether for severe malaria: a meta-analysis of randomized clinical trials.
    Pittler MH; Ernst E
    Clin Infect Dis; 1999 Mar; 28(3):597-601. PubMed ID: 10194084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
    Noubiap JJ
    J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of treating inpatient falciparum malaria on the Thai-Myanmar border.
    Kyaw SS; Drake T; Ruangveerayuth R; Chierakul W; White NJ; Newton PN; Lubell Y
    Malar J; 2014 Oct; 13():416. PubMed ID: 25351915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate versus quinine for treating severe malaria.
    Jones KL; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005967. PubMed ID: 17943870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis.
    Tozan Y; Klein EY; Darley S; Panicker R; Laxminarayan R; Breman JG
    Lancet; 2010 Dec; 376(9756):1910-5. PubMed ID: 21122910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of severe malaria.
    Dondorp AM; Day NP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):633-4. PubMed ID: 17434195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
    Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
    Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artesunate versus quinine for treating severe malaria.
    Sinclair D; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2011 Mar; (3):CD005967. PubMed ID: 21412892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.
    Ferrari G; Ntuku HM; Burri C; Tshefu AK; Duparc S; Hugo P; Mitembo DK; Ross A; Ngwala PL; Luwawu JN; Musafiri PN; Ngoie SE; Lengeler C
    Malar J; 2015 May; 14():226. PubMed ID: 26024661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.